文献速递外周动脉疾病

小动脉疾病(SAD)与中膜动脉钙化(MAC)评分对慢性创面及截肢愈合的影响:能否提供更多信息?

The Impact of Small Artery Disease (SAD) and Medial Arterial Calcification (MAC) Scores on Chronic Wound and Amputation Healing: Can It Tell Us More?
PubMed 文献 · Ann Vasc Surg · 2024-07-25

单中心回顾性研究纳入2015至2020年因慢性足部创面(>1个月)截肢的136条肢体,评估SAD与MAC评分对创面愈合结局的预测价值。MAC评分升高与1年大截肢率更高、创面愈合更差及无截肢生存率更低相关,MAC-2患者截肢风险为MAC-0的5.25倍。MAC评分有望作为现有预测模型的补充。

要点

  • MAC-2患者较MAC-0患者截肢风险更高(HR 5.25,95%CI 1.82–9.77)。
  • MAC评分升高与1年大截肢率更高、创面愈合更差及无截肢生存率更低相关。
  • WIfI联合MAC可能提高对大截肢时间、创面愈合及无截肢生存的预测准确性。

核心结论

  • MAC评分作为长期创面愈合结局的独立预测因子及现有预测模型的补充均显示出显著前景。
  • 在慢性肢体威胁性缺血评估中常规使用MAC评分,尤其当无创检查不可用时,可促进及时转诊干预并在资源有限或重症监护环境中实现高效资源利用。
  • 需进一步研究以确定MAC对血运重建的影响以及评分如何用于指导手术决策。

研究设计与样本

  • 单中心回顾性研究,纳入2015年至2020年因慢性(>1个月)足部创面行截肢的肢体。
  • 要求指数手术前6个月内完成足部X线(MAC)或血管造影(SAD)检查。
  • 共136条肢体,其中67条接受SAD评分(0–2分),128条接受MAC评分(0–2分)。

主要发现

  • 严重(3支血管)踝下病变患者SAD评分均值较高(P=0.001)且MAC评分均值较高(P=0.041)。
  • SAD与MAC均与较低的平均趾压相关(SAD P=0.043,MAC P≤0.001),仅MAC与较高的总体WIfI评分相关(P=0.029)。
  • MAC评分较高者再入院率更高(MAC-2组73.9% vs MAC-0组46.9%,P=0.014),全因死亡率更高(MAC-2组65.2% vs MAC-0组26.0%,P=0.002)。
  • 随MAC严重度增加,1年大截肢率更高(P=0.036)、创面愈合更差(P<0.001)、无截肢生存率更低(P=0.001)。
  • MAC-2患者较MAC-0患者截肢速度更快(HR 5.25,95%CI 1.82–9.77),创面愈合时间更长(HR 0.21,95%CI 0.08–0.53)。

临床怎么用

  • 作者认为,在慢性肢体威胁性缺血评估中常规使用MAC评分,尤其当无创检查不可用时,可促进及时转诊干预并在资源有限或重症监护环境中实现高效资源利用。
  • 作者建议,MAC评分可作为现有预测模型的补充以预测长期创面愈合结局。
  • 作者指出,需进一步研究以确定MAC对血运重建的影响以及评分如何用于指导手术决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2021, Ferraresi et al. created a novel scoring system based on the impact of small artery disease (SAD) and medial arterial calcification (MAC) on wound healing. SAD and MAC scores functioned similar to Wound, Ischemia, and foot Infection (WIfI) but with minimal resource expenditure. Despite its potential, few studies have expanded on the original dataset. We aim to validate SAD's impact and MAC's impact on wound healing outcomes and determine their utility in relation to current predictive models. METHODS: Single-institution retrospective review was used to identify amputations for chronic (>1 month) podiatric wounds between 2015 and 2020. Foot X-ray (MAC) or angiography (SAD) < 6 months of index procedure was required. Primary outcomes included major amputation, wound healing, major adverse limb events, and amputation-free survival (AFS). Statistical analysis included chi-squared, 1-way analysis of variance, nonparametric correlation, Kaplan-Meier, Cox regression, and Akaike/Bayesian Inclusion Criteria model comparison. RESULTS: Of 136 limbs, 67 received SAD scores (0-2) and 128 received MAC scores (0-2). SAD cohorts exhibited similar comorbidity profiles with exception of coronary disease, heart failure, and chronic kidney disease. MAC cohorts were notably disparate in prevalence of multiple conditions. High mean SAD/MAC scores were seen in severe (3-vessel) below-ankle disease (P = 0.001∗ [SAD], P = 0.041∗ [MAC]). Both SAD and MAC correlated with lower mean toe pressure (P = 0.043∗ [SAD], P ≤ 0.001∗ [MAC]), while only MAC correlated with higher overall WIfI score (P = 0.029∗). No significant procedural differences were noted. However, higher readmission rates (73.9% [2] vs. 46.9% [0], P = 0.014∗) and all-cause mortality (65.2% [2] vs. 26.0% [0], P = 0.002∗) were noted with higher MAC. Survival analysis revealed higher 1-year major amputation rates (P = 0.036∗), impaired wound healing (P < 0.001∗), and lower AFS (P = 0.001∗) with increasing MAC severity. Additionally, MAC-2 patients underwent amputation at faster rates than MAC-0 patients (hazard ratio 5.25, 95% confidence interval [1.82, 9.77]) with longer times to wound healing (hazard ratio 0.21, 95% confidence interval [0.08, 0.53]). Model comparison suggested a combination of WIfI and MAC could improve accuracy of predicted time to major amputation, wound healing, and AFS. CONCLUSIONS: MAC scoring showed significant promise both as individual predictor and adjunct to current predictive models of long-term wound healing outcomes. Routine use of MAC scoring in chronic limb-threatening ischemia evaluation, especially when noninvasive testing is unavailable, could promote timely referral for intervention and efficient resource utilization in limited-resource or critical care settings. Furthermore investigation is necessary to determine MAC's impact on revascularization and how scoring can be used to guide surgical decision-making.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sundaram S, Barksdale C, Rodriguez S, et al. The Impact of Small Artery Disease (SAD) and Medial Arterial Calcification (MAC) Scores on Chronic Wound and Amputation Healing: Can It Tell Us More? Ann Vasc Surg. 2024. PMID: 39059628. doi:10.1016/j.avsg.2024.07.089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。